Genetic aspects of drug disposition and therapeutics

Journal of Clinical Pharmacology
R J Guttendorf, P J Wedlund

Abstract

No abstract listed.

References

Sep 17, 1977·Lancet·A MahgoubR L Smith
Sep 1, 1979·European Journal of Clinical Pharmacology·M EichelbaumH J Dengler
Jan 1, 1979·Diabetes·J Scott, P L Poffenbarger
Mar 1, 1978·Life Sciences·J R IdleR L Smith
Feb 12, 1977·British Medical Journal·J H SilasT R Marten
Feb 15, 1975·Biochemical Pharmacology·E S Vesell
Jan 1, 1990·British Journal of Clinical Pharmacology·C J SpeirsA R Boobis
Oct 1, 1990·British Journal of Clinical Pharmacology·A R Boobis, D S Davies
Apr 1, 1990·British Journal of Clinical Pharmacology·R J GuttendorfP J Wedlund
Jan 1, 1990·Pharmacology & Therapeutics·R Ayesh, R L Smith
Feb 28, 1989·Biochemical and Biophysical Research Communications·L KiffelJ P Leroux
Nov 1, 1989·British Journal of Clinical Pharmacology·A S GrossM Eichelbaum
Jan 1, 1989·Pharmacology & Therapeutics·D D BreimerP A Soons
Aug 12, 1989·Lancet·R H WaringA C Williams
Jan 1, 1989·European Journal of Clinical Pharmacology·K Brøsen, L F Gram
Dec 1, 1989·Journal of Neurology·K KanekoT Miyatake
Jan 1, 1989·Pharmacology & Therapeutics·D A Evans
Jan 1, 1989·European Journal of Clinical Pharmacology·L P BalantC von Bahr
Jan 1, 1989·Pharmacology & Therapeutics·R Weinshilboum
Jan 1, 1989·Therapeutic Drug Monitoring·T EbnerM Eichelbaum
Aug 1, 1989·Clinical Pharmacology and Therapeutics·L LennardR M Weinshilboum
Aug 1, 1989·British Journal of Clinical Pharmacology·J O AtibaG R Wilkinson
Jan 1, 1985·European Journal of Clinical Pharmacology·R L Smith
Jan 1, 1989·Clinical Pharmacology and Therapeutics·S A WardR A Branch
Jan 1, 1988·British Journal of Clinical Pharmacology·T InabaT D Arias
Jan 1, 1987·European Journal of Clinical Pharmacology·W Kalow
Apr 1, 1987·British Journal of Clinical Pharmacology·T IshizakiH J Dengler
Jan 1, 1986·European Journal of Clinical Pharmacology·T LeemannU A Meyer
May 1, 1986·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·C von BahrK Woodhouse
Sep 1, 1986·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E JacqzR A Branch
Oct 1, 1985·Clinical Pharmacology and Therapeutics·A Küpfer, R A Branch

❮ Previous
Next ❯

Citations

Nov 1, 1993·Journal of Clinical Pharmacology·M PaoliniG Cantelli-Forti
Jul 1, 1995·Journal of Clinical Pharmacology·W A Colburn
Jan 1, 1993·European Journal of Clinical Pharmacology·N FeifelC H Gleiter
Apr 1, 1994·Pharmacology & Therapeutics·R L Nation, L N Sansom
Sep 5, 2002·British Journal of Clinical Pharmacology·Benedetta C SallustioRaymond G Morris
Jul 25, 2000·Journal of Clinical Pharmacy and Therapeutics·N PoolsupT L Knight
Aug 10, 2011·Biopharmaceutics & Drug Disposition·Jiang Ping LuoJim Fang
Jan 1, 1996·Journal of the American Academy of Dermatology·K J SmithP Angritt
Jun 28, 2005·Epilepsy & Behavior : E&B·Thomas N Ferraro, Russell J Buono
Oct 27, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Lauren M Brignac-HuberWayne L Backes
Mar 1, 1997·Canadian Journal of Physiology and Pharmacology·M Jurima-RometS Geertsen
Dec 10, 1999·Journal of Clinical Psychopharmacology·D J GreenblattR I Shader

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.